BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Treatment
212 results:

  • 1. A Case Report of Kidney Transplantation in a Patient With Pre-existing Chronic Myeloid leukemia: The Role of Achieving Molecular Response and treatment-Free Remission.
    Pinlac V; Bonifacio L
    Transplant Proc; 2024 Apr; 56(3):738-741. PubMed ID: 38538381
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Immune Reconstitution after BTKi treatment in Chronic Lymphocytic leukemia].
    Wang YL; Tang PX; Chen KL; Guo GY; Long JL; Zou YQ; Liang HY; Xu ZS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):1-5. PubMed ID: 38387891
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Henoch-Schonlein Purpura, an Unusual Presentation of Acute Myeloid leukemia.
    Butt MA; Aamer S; Kapetanos A
    Anticancer Res; 2023 Aug; 43(8):3579-3582. PubMed ID: 37500160
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Symptomatic osteonecrosis in French survivors of childhood and adolescent leukemia: a clinical and MRI study of LEA cohort.
    Huault A; Michel G; Charon V; Chouklati K; Domenech C; Chastagner P; Dalle JH; Paillard C; Ducassou S; Poirée M; Plat G; Tabone MD; Kanold J; Baruchel A; Berger C; Pellier I; Plantaz D; Theron A; Mustafa A; Auquier P; Gandemer V
    Pediatr Hematol Oncol; 2023; 40(5):458-474. PubMed ID: 36820621
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Rare Pattern of Myelodysplastic Syndrome (MDS) with Serum Monoclonal Immunoglobulin: Case Report.
    Lin Y; He J; Li F; Gu X
    Altern Ther Health Med; 2023 Apr; 29(3):266-270. PubMed ID: 36735715
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.
    Chang A; Akhtar A; Lai L; Orellana-Noia VM; Linderman SL; McCook-Veal AA; Switchenko JM; Saini M; Valanparambil RM; Blum KA; Allen PB; Lechowicz MJ; Romancik JT; Ayers A; Leal A; O'Leary CB; Churnetski MC; Baird K; Kives M; Wrammert J; Nooka AK; Koff JL; Dhodapkar MV; Suthar MS; Cohen JB; Ahmed R
    Cancer Res Commun; 2022 Dec; 2(12):1684-1692. PubMed ID: 36644323
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience.
    Baratè C; Caruso T; Mavilia F; Sammuri P; Pratesi F; Motta G; Guerri V; Galimberti S; Migliorini P
    Clin Exp Med; 2023 Aug; 23(4):1197-1203. PubMed ID: 36074205
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an iga2 variant of daratumumab.
    Baumann N; Arndt C; Petersen J; Lustig M; Rösner T; Klausz K; Kellner C; Bultmann M; Bastian L; Vogiatzi F; Leusen JHW; Burger R; Schewe DM; Peipp M; Valerius T
    Front Immunol; 2022; 13():949140. PubMed ID: 36052078
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. B-lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting.
    Mikhailova E; Itov A; Zerkalenkova E; Roumiantseva J; Olshanskaya Y; Karachunskiy A; Novichkova G; Maschan M; Popov A
    Cytometry B Clin Cytom; 2022 Sep; 102(5):353-359. PubMed ID: 35796438
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance).
    Symonds L; Yu M; Zhang Y; Ou FS; Zemla TJ; Carter K; Bertagnolli M; Innocenti F; Bosch LJ; Meijer GA; Carvalho B; Grady WM; Cohen SA
    Epigenetics; 2022 Dec; 17(12):1715-1725. PubMed ID: 35412430
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinical Effect of Bazhen Decoction Combined with Sequential treatment of Chemotherapy on Acute Lymphoblastic leukemia Patients with Deficiency of Qi and Yin].
    Niu ZE; Jing DX; Xu CY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):119-125. PubMed ID: 35123613
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A Systematic Review of Health Technology Assessments of Chimeric Antigen Receptor T-Cell Therapies in Young Compared With Older Patients.
    Gye A; Goodall S; De Abreu Lourenco R
    Value Health; 2022 Jan; 25(1):47-58. PubMed ID: 35031099
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia.
    Parry H; McIlroy G; Bruton R; Damery S; Tyson G; Logan N; Davis C; Willett B; Zuo J; Ali M; Kaur M; Stephens C; Brant D; Otter A; McSkeane T; Rolfe H; Faustini S; Richter A; Lee S; Wandroo F; Shafeek S; Pratt G; Paneesha S; Moss P
    J Hematol Oncol; 2022 Jan; 15(1):3. PubMed ID: 35000597
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A B-cell developmental gene regulatory network is activated in infant AML.
    Bolouri H; Ries R; Pardo L; Hylkema T; Zhou W; Smith JL; Leonti A; Loken M; Farrar JE; Triche TJ; Meshinchi S
    PLoS One; 2021; 16(11):e0259197. PubMed ID: 34793513
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
    Mustafa SS; Jamshed S; Vadamalai K; Ramsey A
    PLoS One; 2021; 16(10):e0258529. PubMed ID: 34653210
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impact.
    Krzisch D; Guedes N; Boccon-Gibod C; Baron M; Bravetti C; Davi F; Armand M; Smagghe L; Caron J; Bernard OA; Susin S; Chapiro E; Leblond V; Nguyen-Khac F; Roos-Weil D;
    Am J Hematol; 2021 Dec; 96(12):1569-1579. PubMed ID: 34462944
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia.
    Parry H; McIlroy G; Bruton R; Ali M; Stephens C; Damery S; Otter A; McSkeane T; Rolfe H; Faustini S; Wall N; Hillmen P; Pratt G; Paneesha S; Zuo J; Richter A; Moss P
    Blood Cancer J; 2021 Jul; 11(7):136. PubMed ID: 34330895
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.
    Benjamini O; Rokach L; Itchaki G; Braester A; Shvidel L; Goldschmidt N; Shapira S; Dally N; Avigdor A; Rahav G; Lustig Y; Ben David SS; Fineman R; Paz A; Bairey O; Polliack A; Levy I; Tadmor T
    Haematologica; 2022 Mar; 107(3):625-634. PubMed ID: 34320789
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Invasive aspergillosis and endocarditis.
    Chevalier K; Barde F; Benhamida S; Le Meur M; Thyrault M; Bentoumi Y; Lau N; Lebut J
    Rev Med Interne; 2021 Oct; 42(10):678-685. PubMed ID: 34303547
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Burkitt leukemia with precursor B-cell features that developed after ruxolitinib treatment in a patient with hydroxyurea-refractory JAK2
    Fukutsuka K; Iioka F; Maekawa F; Nakagawa M; Kishimori C; Hayashida M; Tagawa S; Akasaka T; Honjo G; Ohno H
    J Clin Exp Hematop; 2021 Jun; 61(2):114-119. PubMed ID: 33994432
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.